EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$3.65
-0.36 (-8.98%)
As of Sep 28, 10:42 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +725.8% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $3.65
Current
$3.65
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
518.6%
Low target
Base Case
$30.14
+725.8%
Avg target
Bull Case
$41.69
+1,042.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$20.32
-82.0% from high
52-Week Low
$0.72
+406.9% from low
Target vs 52W High
$30.14
+48.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%